Introduction. and aryl-α-amino ketones, 11

Similar documents
176 YMC Chiral Columns

Impact of Reversed-Phase Chiral Chromatography on the LC-MS Analysis of Drugs in Biological Fluids

Enantioresolution of Amphetamine, Methamphetamine, and Deprenyl (Selegiline) by LC, GC, and CE

Macrocyclic Chiral Stationary Phases

A Validated Chiral Liquid Chromatographic Method for The Enantiomeric Separation of Dapoxetine Hydrochloride

Tenofovir disoproxil fumarate (Tenofoviri disoproxili fumaras)

A New HILIC/RP Mixed-Mode Column and Its Applications in Surfactant Analysis

Separation of Macrocyclic Lactones (Avermectins) on FLARE C18 MM & FLARE C18+ Columns

Enantioseparation condition of D,L-tryptophan using ligand exchange chromatography

Journal of Chemical and Pharmaceutical Research, 2012, 4(11): Research Article

John P. McCauley and Rui Chen Waters Corporation, Milford, MA, USA INTRODUCTION APPLICATION BENEFITS WATERS SOLUTIONS KEY WORDS

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

Application Note. Abstract. Authors. Pharmaceutical

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

International Journal of Pharma and Bio Sciences

column If you would like a subscription, or more information, please contact your nearest Waters Office.

RP-HPLC METHOD DEVELOPMENT FOR THE QUANTIFICATION OF GABAPENTIN IN FORMULATIONS

F. Al-Rimawi* Faculty of Science and Technology, Al-Quds University, P.O. Box 20002, East Jerusalem. Abstract

Improved Pirkie Type 1 Amide Type: Asymmetric carbon atoms are bonded directly with CONH group

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS TOLBUTAMIDE IN PURE AND PHARMACEUTICAL FORMULATIONS

Organic Chemistry Laboratory Fall Lecture 3 Gas Chromatography and Mass Spectrometry June

Achiral SFC: Development of an Orthogonal SFC Method for Mometasone Furoate Impurity Analysis

Impurity Profiling of Carbamazepine by HPLC/UV

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS

SEPARATION OF ENANTIOMERS BY CHIRALLY MODIFIED MEMBRANES

LC/MS Analysis of Various Hydrophilic Compounds Using a Polymer-Based Amino Column - Shodex TM HILICpak TM VG-50 2D

Title Revision n date

Determination of enantiomeric purity of Timolol Maleate by Supercritical Fluid Chromatography

CHROMATOGRAPHIC ANALYSIS OF ORGANIC COMPOUNDS ON IMPREGNATED CHEMICALLY BONDED STATIONARY PHASES. PART 1

Analytical and Preparative SFC Columns

Oligosaccharide Profiling of O-linked Oligosaccharides Labeled with 2 Aminobenzoic Acid (2-AA)

Reverse Phase HPLC Analysis of Atomoxetine in Pharmaceutical Dosage Forms

Analytical Method Development for USP Related Compounds in Paclitaxel Using an Agilent Poroshell 120 PFP

Separation of Perillyl Alcohol from the Peel of Citrus Unshiu by Supercritical CO 2 and Preparative High-Performance Liquid Chromatography

COSMOSIL CHiRAL Series

Type Analysis of Citrus Essential Oils by Multidimensional Supercritical Fluid Chromatography/ Gas Chromatography

Supporting Information

Characterization and application of single-isomer cyclodextrin derivatives

Application Note. Authors: C. Ledesma, M. Gibert, J.R. Gibert Ingenieria Analitica S.L. Extracts from various food products

Automated Purification and Analytical Reinjection of a Small Molecule Drug, Probenecid, on a Gilson LC/MS Dual Function System

Implementing a Generic Methods Development Strategy for Enantiomer Analysis

Heparin Sodium ヘパリンナトリウム

Robust and Fast Analysis of Tobacco-Specific Nitrosamines by LC-MS/MS

Fast Separation of Triacylglycerols in Oils using UltraPerformance Convergence Chromatography (UPC 2 )

CHAPTER 8 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) ANALYSIS OF PHYTOCHEMICAL CONSTITUENTS OF M. ROXBURGHIANUS AND P. FRATERNUS PLANT EXTRACTS

Enantiomeric Separation and Circular Dichroism Detection of Metalaxyl Acid Metabolite by Chiral High Performance Liquid Chromatography

ARTENIMOLUM ARTENIMOL. Adopted revised text for addition to The International Pharmacopoeia

April Determination of Sucralose in Foods by HPLC

GlycanPac AXR-1 Columns

Separation of Saccharides Using TSKgel Amide-80, a Packing Material for High-performance Normal Phase Partition Chromatography (2) Table of Contents

Ultra Columns. also available. ordering note

Bangladesh J. Bot. 46(4): , 2017 (December)

Barry Boyes 1,2, Shujuan Tao 2, and Ron Orlando 2

SIMPLE AND VALIDATED RP-HPLC METHOD FOR THE ESTIMATION OF CARBOPLATIN IN BULK AND FORMULATION DOSAGE FORM. Subhashini.Edla* B.

Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method

Level and activity of D-amino acids in mouse brain tissue and blood

Separation of Vitamin D and Vitamin D Metabolites on FLARE C18 MM (Mixed Mode) HPLC Column

Chemical Biology of Tea Catechins

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006)

Validated RP- HPLC Method for the Quantitative Estimation of Valsartan in Bulk and Pharmaceutical Dosage Forms

Hyderabad, India. Department of Pharmaceutical Chemistry, Glocal University, Saharanpur, India.

C. Randall Clark* and Jack DeRuiter. F. Taylor Noggle. Abstract. Introduction

Selectivity Comparison of Agilent Poroshell 120 Phases in the Separation of Butter Antioxidants

SIMULTANEOUS ESTIMATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN TABLETS BY RP-HPLC METHOD

Sepax Technologies, Inc.

Student Handout. This experiment allows you to explore the properties of chiral molecules. You have

Using Hydrophilic Interaction Chromatography (HILIC) for the Retention of Highly Polar Analytes

Methotrexate. (Ph. Eur. monograph 0560) C 20 H 22 N 8 O Action and use. Dihydrofolate reductase inhibitor; cytostatic.

ISSN: ; CODEN ECJHAO E-Journal of Chemistry 2011, 8(3),

Standardization of a LC/MS/MS Method for the Determination of Acyl Glucuronides and Their Isomers

Comparison of a UPLC Method across Multiple UHPLC Systems

A Reverse Phase HPLC Method Development and Validation for the Determination of Paliperidone in Pure and Dosage Forms

Wonku Kang a, Dong-Jun Lee a, Kwang-Hyeon Liu a, Yu Eun Sunwoo a, Kwang-il Kwon b, In-June Cha a, Jae-Gook Shin a,

Vol. 43, No. 6. Simple Analysis of Maleic Hydrazide in Agricultural Products by HPLC

Facile t-boc and FMOC Amino Acid Chiral Separations by HPLC

Systematic Evaluation of Solid Phase Extraction (SPE) Chemistries for the Determination of Acidic, Neutral, and Basic Drugs

Simultaneous Quantification of 13 Ginsenosides by LC-MS/MS and its Application in Diverse Ginseng Extracts

SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010)

Estimation of Emtricitabine in Tablet Dosage Form by RP-HPLC

Volume 2 (6), 2014, Page CODEN (USA)-IJPRUR, e-issn: International Journal of Pharma Research and Health Sciences

ACE C18-AR Use the Power!

Supplementary Material

August Determination of Pindone in Agricultural Products by LC-MS/MS

C30 ISOMERS HAVE MET THEIR MATCH

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

HPLC Analysis of Sugars

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

Supporting Information

PAPRIKA EXTRACT SYNONYMS DEFINITION DESCRIPTION FUNCTIONAL USES CHARACTERISTICS

ABACAVIR SULFATE Proposal for revision of The International Pharmacopoeia (August 2012)

Immobilized Chiral Stationary Phases

DEXAMETHASONE. First draft prepared by Bruno LE BIZEC, Nantes, France

Journal of Chemical and Pharmaceutical Research

Fortis Method Development Options

LC Columns with Liquid Separation Cell Technology

High-Resolution Analysis of Intact Triglycerides by Reversed Phase HPLC Using the Agilent 1290 Infinity LC UHPLC System

Development and Validation of a RPLC Method for the Determination of 2-Phenoxyethanol in Senselle Lubricant Formulation

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

LC-MS/MS Method for the Determination of Tenofovir from Plasma

Studies on stereoselective separations of the azole antifungal drugs ketoconazole and itraconazole using HPLC and SFC on silica-based polysaccharides

Transcription:

Enantiomeric Resolution of γ-amino Acids Bull. Korean Chem. Soc. 2011, Vol. 32, No. 8 3017 DOI 10.5012/bkcs.2011.32.8.3017 Liquid Chromatographic Resolution of Vigabatrin and Its Analogue γ-amino Acids on Chiral Stationary Phases Based on (3,3 -Diphenyl-1,1 -binaphthyl)-20-crown-6 Hee Jung Choi, Hwan Sun Cho, Su Jin Lee, and Myung Ho Hyun * Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Pusan 609-735, Korea. * E-mail: mhhyun@pusan.ac.kr Received February 23, 2011, Accepted May 3, 2011 Two chiral stationary phases (CSPs) based on (3,3 -diphenyl-1,1 -binaphthyl)-20-crown-6 bonded covalently to silica gel were applied for the first time to the resolution of racemic vigabatrin and its analogue γ-amino acids and the resolution results were compared to those on the commercially available Crownpak CR(+) based on (3,3 -diphenyl-1,1 -binaphthyl)-20-crown-6 coated dynamically onto octadecylsilica gel. While vigabatrin was not resolved at all on Crownpak CR(+), it was resolved quite well on the two CSPs. Among four vigabatrin analogue γ-amino acids, only two were resolved on Crownpak CR(+), but three were resolved on the CSP (CSP 1) containing residual silanol groups and all of four were resolved on the CSP (CSP 2) containing residual silanol group-protecting n-octyl groups. The improved lipophilicity in CSP 2 was proposed to be responsible for its superiority to CSP 1 for the resolution of vigabatrin and analogue γ-amino acids. In addition, the composition of aqueous mobile phase was found to affect the chiral recognition behaviors for the resolution of vigabatrin and analogue γ-amino acids on CSP 2. Key Words : Chiral stationary phase, Chiral crown ether, Enantiomeric resolution, Liquid chromatography, Vigabatrin, γ-amino acids Introduction Liquid chromatographic chiral stationary phases (CSPs) based on chiral crown ethers have been known to be very useful for the resolution of racemic compounds containing a primary amino group. 1 Especially, a CSP based on (3,3 - diphenyl-1,1 -binaphthyl)-20-crown-6 covalently bonded to silica gel (CSP 1, Fig. 1) was very successful in the resolution of racemic α-amino acids, 2 β-amino acids, 3 cyclic and non-cyclic amines, 4 amino alcohols, 4 various fluoroquinolone antibacterials, 5 tocainide (antiarrhythmic agent) and its analogues, 6 and aryl-α-amino ketones. 7 Another CSP prepared by treating CSP 1 with n-octyltriethoxysilane (CSP 2, Fig. 1) was also very successful in the resolution of α- amino acids, 8 β-amino acids, 3 cyclic and non-cyclic amines, 8 amino alcohols, 8 various fluoroquinolone antibacterials, 9 tocainide (antiarrhythmic agent) and its analogues, 10 and aryl-α-amino ketones, 11 the chiral recognition efficiency of CSP 2 being even greater than that of CSP 1. However, CSP 1 and CSP 2 have not been utilized in the resolution of vigabatrin and its analogue γ-amino acids. Vigabatrin (3, 4-amino-5-hexenoic acid, Fig. 2), a structural analogue of the inhibitory neurotransmitter γ-amino acid (4- aminobutyric acid, GABA, Fig. 2), is an anticonvulsant drug used for the treatment of epilepsy. 12 Vigabatrin is a chiral compound. Even though only the (S)-(+)-enantiomer has been reported to posses pharmacological activity, 13 vigabatrin is supplied as a racemic mixture. In addition, the two This paper is dedicated to Professor Eun Lee on the occasion of his honourable retirement. Figure 1. Structures of CSP1, CSP 2 and Crowmpak CR(+). enantiomers of vigabatrin have been reported to show different pharmacokinetics and pharmacological activity after epileptic patients was treated with racemic vigabatrin. 14

3018 Bull. Korean Chem. Soc. 2011, Vol. 32, No. 8 Hee Jung ChoiGet al. Figure 2. Structures of vigabatrin (3), γ-aminobutyric acid (GABA), 4-amino-4-phenylbutanoic acid (4), 4-amino-5-phenylpentanoic acid (5), 4-amino-5-(1-naphthyl)pentanoic acid (6) and 4-amino-5-(2- naphthyl)pentanoic acid (7). In this instance, the determination of the enantiomeric composition of vigabatrin is very important. For the determination of the content of vigabatrin in plasma or serum, gas chromatography-mass spectrometry (GC-MS) or gas-liquid chromatography (GLC) has been utilized. 15 Vigabatrin derivatized with chiral derivatizing agents have been resolved as diastereomers by high performance liquid chromatography (HPLC) or by capillary electrophoresis (CE) method. 14,16 However, the direct resolution of vigabatrin by HPLC without derivatization is rare. Recently, a CSP based on (+)-(18-crown-6)-2,3,11,12-tetracarboxylic acid was successfully utilized in the resolution of vigabatrin and its analogue γ-amino acids. 17 In addition, macrocyclic glycopeptide antibiotic CSPs based on teicoplanin aglycone were used for the resolution and quantification of the two enantiomers of vigabatrin and γ-amino acids. 18 As another example for the direct resolution of vigabatrin and its analogue γ-amino acids, in this study, we report that CSP 1 and CSP 2 can be successfully applied to the resolution of vigabatrin and its analogue γ-amino acids. Experimental Chromatography was performed with an HPLC system consisting of a Waters model 510 HPLC Pump (Milford, MA, USA), a Rheodyne model 7725i injector (Rohnert Park, CA, USA) with a 20 µl sample loop, Waters 486 tunable absorbance detector (Milford, MA, USA) and Younglin Autochro data module (Software: YoungLin Autochro-WIN 2.0 plus) (Seoul, Korea). Chiral columns packed with CSP 1 (250 4.6 mm i.d.) and CSP 2 (150 4.6 mm i.d.) were available from prior studies. 2,8 Crownpak CR(+) column (150 4.6 mm i.d., Fig. 1) was commercially available from Daicel Chemical Industries (Tokyo, Japan). Vigabatrin (3) and its analogue γ-amino acids (4-7) shown in Fig. 2 were available from prior study. 17 The temperature of the chiral columns was maintained at 20 o C by using a Julabo F30 Ultratemp 2000 cooling circulator (Seelbach, Germany). Injection samples were prepared by dissolving analytes in water (vigabatrin) or in methanol (other γ-amino acids) at a concentration of 1.0 mg/ml and an injection size was typically 3 µl. Results and Discussion Previously, vigabatrin was attempted to be resolved without derivatization by HPLC using the Crownpak CR(+) based on (3,3 -diphenyl-1,1 -binaphthyl)-20-crown-6 dynamically coated onto octadecyl silica gel, but it was not successful. 19 The chiral selector of Crownpak CR(+), (3,3 - diphenyl-1,1 -binaphthyl)-20-crown-6, is identical to that of CSP 1 and CSP 2. In this instance, we tried to compare the chiral recognition abilities of Crownpak CR(+), CSP 1 and CSP 2 for the resolution of vigabatrin (3) and its analogue γ- amino acids (4-7). The chromatographic results for the resolution of vigabatrin (3) and its analogue γ-amino acids (4-7) on Crownpak CR(+), CSP 1 and CSP 2 are summarized in Table 1. As shown in Table 1, vigabatrin was not resolved at all on Crownpak CR(+), but analytes 4 and 5 were resolved. Analytes 6 and 7 were found to be not eluted from the chiral column probably because of the long retention times. The chromatographic resolution on Crownpak CR(+) was performed with the use of 15% methanol in water containing sulfuric acid (10 mm) as a mobile phase. Because of the dynamically coated nature of the Crownpak CR(+), the use of a mobile phase containing more than 15% methanol results in leaching of the chiral crown selector from the chiral column. 20 Consequently, we did not try to use other mobile phase condition. Vigabatrin was resolved best with the separation factor (α) of 1.45 and the resolution (R S ) of 1.86 on CSP 1 when 80% acetonitrile in water containing sulfuric acid (10 mm) and ammonium acetate (1.0 mm) was used as a mobile phase as shown in Table 1. The identical mobile phase was applied to Table 1. Resolution of vigabatrin (3) and its analogue γ-amino acids 4-7 on Crownpak CR(+), CSP 1 and CSP 2 a Analytes Crownpak CR(+) CSP 1 CSP 2 k 1 α Rs k 1 α Rs k 1 α Rs 3 1.26 1.00 1.43 1.45 1.86 2.11 1.73 2.19 4 8.70 1.45 2.17 1.01 2.11 3.08 1.66 2.56 4.74 5 8.52 1.11 0.94 0.68 1.17 1.25 0.68 1.29 3.83 6 0.68 1.00 1.94 1.10 0.51 7 0.70 1.08 0.59 1.91 1.59 2.13 a Mobile phase: 15% Methanol in water containing sulfuric acid (10 mm) on Crownpak CR(+), 80% acetonitrile in water containing sulfuric acid (10 mm) and ammonium acetate (1.0 mm) on CSP 1 and 80% methanol in water containing sulfuric acid (10 mm) and ammonium acetate (1.0 mm) on CSP 2. Flow rate: 0.5 ml/min. Detection: 214 nm UV for analyte 3 and 254 nm UV for analytes 4-7. Temperature: 20 o C. k 1: Retention factor of the first eluted enantiomer. α: Separation factor. R S: Resolution factor.

Enantiomeric Resolution of γ-amino Acids Bull. Korean Chem. Soc. 2011, Vol. 32, No. 8 3019 the resolution of other analytes on CSP 1. Analytes 4 and 5 were also resolved well on CSP 1, but analyte 6 was not resolved at all and analyte 7 was resolved only slightly with the resolution (R S ) of 0.59. In contrast, vigabatrin was resolved with the separation factor (α) of 1.73 and the resolution (R S ) of 2.19 on CSP 2 when 80% methanol in water containing sulfuric acid (10 mm) and ammonium acetate (1.0 mm) was used as a mobile phase as shown in Table 1. Under the identical mobile phase condition, other analytes (4-7) were resolved on CSP 2. In every case, CSP 2 was found to be better than CSP 1 in the resolution of vigabatrin and its analogue γ-amino acids. Previously, it was concluded from the chromatographic results for the resolution of various racemic primary amino compounds on CSP 1 and CSP 2 that the protection of the residual silanol groups of CSP 1 with lipophilic n-octyl groups can considerably improve its chiral recognition ability. 3,8-11 Removal of the non-enantioselective interaction between the residual silanol groups and racemic analytes by the protection of the residual silanol groups of CSP 1 with n- octyl groups might be responsible for the higher chiral recognition ability of CSP 2 compared to that of CSP 1. 3 However, this effect should be limited under highly polar aqueous mobile phase condition. Instead, the additional n- octyl protecting groups make CSP 2 more lipophilic than CSP 1 and the improved lipophilicity of CSP 2 might be responsible for the higher chiral recognition ability of CSP 2 compared to that of CSP 1 even though the reason is not clear yet. 3 In order to see the effect of mobile phase composition on the chiral recognition ability of CSP 2 for the resolution of vigabatrin and its analogue γ-amino acids, we selected three analytes (3, 4 and 7) and resolved them on CSP 2 with the variation of the composition of aqueous mobile phase. The chromatographic results for the resolution of selected three analytes (3, 4 and 7) on CSP 2 with the variation of the composition of aqueous mobile phase are summarized in Table 2. As shown in Table 2, as the content of methanol in water containing sulfuric acid (10 mm) and ammonium acetate (1.0 mm) was increased from 30% to 50% and then to 80%, the retention times denoted by the retention factors (k 1 ) decrease continuously (see entry a in Table 2). Especially, the retention factor for analyte 7, which is probably most lipophilic, was found to decrease dramatically. The representative chromatograms for the resolution of analyte 4 on CSP 2 with the variation of the methanol content in aqueous mobile phase containing sulfuric acid (10 mm) and ammonium acetate (1.0 mm) shown in Fig. 3 clearly demonstrate the retention behaviors. As the content of methanol in aqueous mobile phase is increased, the mobile phase polarity decrease and consequently, the lipophilic interaction between the analyte and the quite lipophilic CSP is expected to decrease. In this instance, the retention of the analyte decreases. The separation factors (α) and resolutions (R S ) for the resolution of analyte 3 and 4 were found to increase as the content of methanol in aqueous mobile phase is increased, but those for the resolution of analyte 7 were found not to change notably. The use of acetonitrile instead of methanol in aqueous mobile phase containing sulfuric acid (10 mm) and ammonium acetate (1.0 mm) was found to be also useful for the resolution of selected three analytes (3, 4 and 7) on CSP 2 (see entry a in Table 2). Acidic modifier added to the mobile phase is used to protonate the primary amino group of analytes. The resulting primary ammonium ion (R-NH 3 +) of analyte has been Table 2. Resolution of selected analytes 3, 4 and 7 on CSP 2 with the variation of the composition of aqueous mobile phase a Mobile phase 3 4 7 k 1 α Rs k 1 α Rs k 1 α Rs a b c d 30% CH 3OH + 10 mm H 2SO 4 + 1.0 mm CH 3CO 2NH 4 3.37 1.23 1.08 8.68 1.90 2.62 62.85 1.57 2.19 50% CH 3OH + 10 mm H 2SO 4 + 1.0 mm CH 3CO 2NH 4 3.30 1.27 1.40 5.00 1.98 3.20 13.77 1.59 2.83 50% CH 3CN + 10 mm H 2SO 4 + 1.0 mm CH 3CO 2NH 4 3.06 1.27 2.02 1.84 2.20 5.12 2.44 1.33 2.60 80% CH 3CN + 10 mm H 2SO 4 + 1.0 mm CH 3CO 2NH 4 3.01 1.45 1.47 1.36 3.20 6.98 1.01 1.26 1.36 80% CH 3OH + 10 mm HClO 4 + 1.0 mm CH 3CO 2NH 4 2.46 1.62 1.99 1.85 2.50 4.76 2.14 1.56 2.36 80% CH 3OH + 10 mm TFA + 1.0 mm CH 3CO 2NH 4 2.29 1.00 2.55 2.49 4.81 1.98 1.56 2.87 80% CH 3OH + 10 mm AcOH + 1.0 mm CH 3CO 2NH 4 2.24 1.32 1.31 1.72 1.97 2.90 1.54 1.34 1.75 80% CH 3OH + 5 mm H 2SO 4 + 1.0 mm CH 3CO 2NH 4 2.74 1.31 1.48 1.55 2.65 4.97 1.80 1.61 3.00 80% CH 3OH + 2 mm H 2SO 4 + 1.0 mm CH 3CO 2NH 4 2.71 1.31 1.47 1.78 2.46 2.06 2.01 1.42 2.21 80% CH 3OH + 1 mm H 2SO 4 + 1.0 mm CH 3CO 2NH 4 2.79 1.31 1.21 1.88 2.19 2.02 2.01 1.43 2.21 50% CH 3CN + 10 mm H 2SO 4 + 1.0 mm CH 3CO 2NH 4 3.06 1.27 2.09 1.84 2.20 5.21 2.44 1.31 2.60 50% CH 3CN + 10 mm H 2SO 4 + 0.5 mm CH 3CO 2NH 4 4.24 1.24 2.02 4.64 2.22 6.43 6.11 1.29 5.97 50% CH 3CN + 10 mm H 2SO 4 + 0.1 mm CH 3CO 2NH 4 7.21 1.26 1.86 8.33 2.13 3.43 10.70 1.27 3.05 50% CH 3CN + 10 mm H 2SO 4 + 0.0 mm CH 3CO 2NH 4 7.93 1.26 1.82 10.45 2.48 3.42 13.02 1.33 2.68 a Flow rate: 0.5 ml/min. Temperature: 20 o C. Detection: 210 or 254 nm UV. k 1: Retention factor of the first eluted enantiomer.

3020 Bull. Korean Chem. Soc. 2011, Vol. 32, No. 8 Hee Jung ChoiGet al. Figure 3. Chromatograms for the resolution of 4-amino-4- phenylbutanoic acid (4) on CSP 2 with the variation of the content of methanol in water containing sulfuric acid (10 mm) and ammonium acetate (1 mm). Flow rate: 0.5 ml/min. Temperature: 20 o C. Detection: 254 nm UV. Figure 4. Chromatograms for the resolution of 4-amino-4- phenylbutanoic acid (4) on CSP 2 with the variation of the content of ammonium acetate in 50% acetonitrile in water containing sulfuric acid (10 mm). Flow rate: 0.5 ml/min. Temperature: 20 o C. Detection: 254 nm UV. proposed to be used for the enantioselective complexation inside the cavity of the crown ether ring of the CSP. 1 As an acidic modifier we tested sulfuric acid, perchloric acid, trifluoroacetic acid (TFA) and acetic acid (AcOH). As shown in Table 2 (entry b), sulfuric acid and perchloric acid were found to be quite effective as an acidic modifier in the mobile phase for the resolution of the three selected analytes. Especially, sulfuric acid was found to be most effective for the resolution of vigabatrin (3) in terms of the separation factor and resolution. Trifluoroacetic acid was not effective at all for the resolution of vigabatrin (3), but quite effective for the resolution of analytes 4 and 7. Acetic acid was less effective than sulfuric acid or perchloric acid for the resolution of the three selected analytes in terms of the separation factors and resolutions. Changing the content of sulfuric acid in the mobile phase from 1 mm to 5 mm and then to 10 mm does not affect the chiral recognition behaviors significantly. Vigabatrin (3) was resolved best when the content of sulfuric acid in aqueous mobile phase was 10 mm, but analytes 4 and 7 were resolved best when the content of sulfuric acid in aqueous mobile phase was 5 mm (see entry c in Table 2). Ammonium acetate added to the mobile phase is used to reduce the retention times of analytes. Especially, the retention times of analytes on CSP 1 and CSP 2 have been controlled by adding ammonium acetate to the mobile phase. 8-11 The competition for the complexation inside the cavity of the crown ether ring of the CSP between the ammonium ion (NH 4 +) from ammonium acetate and the primary ammonium ion (R-NH 3 +) of analyte is believed to reduce the retention times of analytes. 8-11 Without ammonium acetate, the retention factors of analytes are quite large as shown in Table 2 (entry d). As the content of ammonium acetate in aqueous mobile phase is increased, the retention factors decrease significantly, but the separation factors do not change significantly. The representative chromatograms showing the retention behaviors for the resolution of analyte 4 on CSP 2 with the variation of the content of ammonium acetate in aqueous mobile phase are shown in Fig. 4. The addition of ammonium acetate to aqueous mobile phase was found to improve the resolution factor for vigabatrin (3) continuously. The addition of ammonium acetate (until 0.5 mm) to aqueous mobile phase was also found to improve the resolutions for analytes 4 and 7. However, further addition of ammonium acetate (1.0 mm) to aqueous mobile phase was found to diminish the resolutions for analytes 4 and 7. The addition of a certain amount of ammonium acetate to aqueous mobile phase is expected to increase the mass transfer rate of analytes within the chiral column. In this instance, the peak tailing is diminished and the resolution is expected to increase. However, the addition of ammonium acetate further can reduce the retention times of the two enantiomers quite much and then the resolution which is related to the difference between the retention times of two enantiomers can be diminished. In summary, in this study, we for the first time demonstrated that CSPs based on (3,3 -diphenyl-1,1 -binaphthyl)-20- crown-6 bonded covalently to silica gel are quite useful for the resolution of vigabatrin and its analogue γ-amino acids. Between the two CSPs, CSP 2 containing residual silanol group-protecting n-octyl groups is better than CSP 1 containing residual silanol groups in the resolution of vigabatrin and its analogue γ-amino acids. We also demonstrated that the chromatographic behaviors for the resolution of vigabatrin and its analogue γ-amino acids on CSP 2 can be controlled by changing the composition of aqueous mobile phase. Acknowledgments. This research was supported by NCRC (National Core Research Center) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (grant number: 2010-0008-269). References 1. (a) Hyun, M. H. J. Sep.Sci. 2003, 26, 242. (b) Hyun, M. H. Bull. Kor. Chem. Soc. 2005, 26, 1153. (c) Hyun, M. H. J. Sep.Sci. 2006, 29, 750. (d) Choi, H. J.; Hyun, M. H. J. Liq. Chromatogr. Rel. Technol. 2007, 30, 853. 2. Hyun, M. H.; Han, S. C.; Lipshutz, B. H.; Shin, Y.-J.; Welch, C. J.

Enantiomeric Resolution of γ-amino Acids Bull. Korean Chem. Soc. 2011, Vol. 32, No. 8 3021 J. Chromatogr. A 2001, 910, 359. 3. Choi, H. J.; Ha, H. J.; Han, S. C.; Hyun, M. H. Anal. Chim. Acta 2008, 619, 122. 4. Hyun, M. H.; Han, S. C.; Lipshutz, B. H.; Shin, Y.-J.; Welch, C. J. J. Chromatogr. A 2002, 959, 75. 5. Hyun, M. H.; Han, S. C. J. Biochem. Biophys. Methods 2002, 54, 235. 6. Hyun, M. H.; Min, H. J.; Cho, Y. J. J. Chromatogr. A 2003, 996, 233. 7. Hyun, M. H.; Tan, G.; Cho, Y. J. Biomed. Chromatogr. 2005, 19, 208. 8. Hyun, M. H.; Han, S. C.; Choi, H. J.; Kang, B. S.; Ha, H. J. J. Chromatogr. A 2007, 1138, 169. 9. Choi, H. J.; Cho, H. S.; Han, S. C.; Hyun, M. H. J. Sep. Sci. 2009, 32, 536. 10. Choi, H. J.; Jin, J. S.; Hyun, M. H. Chirality 2009, 21, 11. 11. Choi, H. J.; Jin, J. S.; Hyun, M. H. J. Chromatogr. B 2008, 875, 102. 12. Walker, M. C.; Patsalos, P. N. Pharmacol. Ther. 1995, 67, 351. 13. Meldrum, B. S.; Murugaiah, K. Eur. J. Pharmacol. 1983, 89, 149. 14. Vermeij, T. A. C.; Edelbroek, P. M.; J. Chromatogr. B 1998, 716, 233. 15. (a) Haegele, K. D.; Schoun, J.; Alken, R. G.; Huebert, N. D. J. Chromatogr. 1983, 274, 103. (b) Schramm, T. M.; McKinnon, G. E.; Eadie, M. J. J. Chromatogr. Biomed. Appl. 1993, 616, 39. 16. Zhao, S.; Zhang, R.; Wang, H.; Tang, L.; Pan, Y. J. Chromatogr. B 2006, 833, 186. 17. Lee, S. J; Cho, H. S.; Choi, H. J.; Hyun, M. H. J. Chromatogr. A 2008, 1188, 318. 18. (a) Al-Majed, A. A. J. Pharm. Biomed. Anal. 2009, 50, 96. (b) Pataj, Z.; Ilisz, I.; Aranyi, A.; Forro, E.; Fulop, F.; Armstrong, D. W.; Peter, A. Chromatographia 2010, 71, S13. 19. Walbroehl, Y.; Wagner, J. J. Chromatogr. A 1994, 685, 321. 20. Instruction Manual for Crownpak CR(+), Daicel Chemical Industries.